· Policy & Manufacturing · Source: dtnext.in

Tamil Nadu’s 1st Biosimilar insulin facility in Chennai

Regenix Drugs has commissioned Tamil Nadu’s first biosimilar insulin facility in Chennai, producing Sustaglar, a long-acting glargine insulin. As only the fifth such unit in India, the plant will enhance access to affordable diabetes treatment, especially in rural areas, strengthening Tamil Nadu’s position in the pharmaceutical and healthcare sector.

Read source

Evaluating a similar location, plant, or policy window?

Bucephalus advises on greenfield industrial projects in South India.

Talk to Bucephalus

This page is a curated briefing. The original article belongs to dtnext.in. Bucephalus does not republish the source in full.